Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zaman

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Oncotarget|December 21, 2020
Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascitesJudith E den Ouden, Guido J R Zaman, Jelle Dylus, et al.
Frontiers in Oncology|November 7, 2025
Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancersDaphne J F Kluitmans, Janneke J T M Melis, Esmee van den Bossche, et al.
Molecular Pharmacology|September 28, 2011
Identification of a novel allosteric binding site in the CXCR2 chemokine receptorPetra de Kruijf, Herman D Lim, Luc Roumen, et al.
European Journal of Pharmacology|April 5, 2011
N-acetylated Proline-Glycine-Proline induced G-protein dependent chemotaxis of neutrophils is independent of CXCL8 releaseSaskia A Overbeek, Paul A J Henricks, Anja I Srienc, et al.
Plos One|May 29, 2015
Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing DrugsJoost C M Uitdehaag, Jeroen A D M de Roos, Antoon M van Doornmalen, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 14, 2008
Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptorsDennis Verzijl, Stefania Storelli, Danny J Scholten, et al.
The Journal of Biological Chemistry|January 24, 2013
β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKRAnne O Watts, Folkert Verkaar, Miranda M C van der Lee, et al.
Leukemia|May 14, 2016
MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemiaK Canté-Barrett, J A P Spijkers-Hagelstein, J G C A M Buijs-Gladdines, et al.
Mucosal Immunology|March 6, 2024
The bacterial lysate OM-85 engages Toll-like receptors 2 and 4 triggering an immunomodulatory gene signature in human myeloid cellsHanif J Khameneh, Marco Bolis, Pedro M O Ventura, et al.
Assay and Drug Development Technologies|February 4, 2009
Characterization and optimization of a red-shifted fluorescence polarization ADP detection assayKaren M Kleman-Leyer, Tony A Klink, Andrew L Kopp, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Oncotarget|December 21, 2020
Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascitesJudith E den Ouden, Guido J R Zaman, Jelle Dylus, et al.
Frontiers in Oncology|November 7, 2025
Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancersDaphne J F Kluitmans, Janneke J T M Melis, Esmee van den Bossche, et al.
Molecular Pharmacology|September 28, 2011
Identification of a novel allosteric binding site in the CXCR2 chemokine receptorPetra de Kruijf, Herman D Lim, Luc Roumen, et al.
European Journal of Pharmacology|April 5, 2011
N-acetylated Proline-Glycine-Proline induced G-protein dependent chemotaxis of neutrophils is independent of CXCL8 releaseSaskia A Overbeek, Paul A J Henricks, Anja I Srienc, et al.
Plos One|May 29, 2015
Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing DrugsJoost C M Uitdehaag, Jeroen A D M de Roos, Antoon M van Doornmalen, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 14, 2008
Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptorsDennis Verzijl, Stefania Storelli, Danny J Scholten, et al.
The Journal of Biological Chemistry|January 24, 2013
β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKRAnne O Watts, Folkert Verkaar, Miranda M C van der Lee, et al.
Leukemia|May 14, 2016
MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemiaK Canté-Barrett, J A P Spijkers-Hagelstein, J G C A M Buijs-Gladdines, et al.
Mucosal Immunology|March 6, 2024
The bacterial lysate OM-85 engages Toll-like receptors 2 and 4 triggering an immunomodulatory gene signature in human myeloid cellsHanif J Khameneh, Marco Bolis, Pedro M O Ventura, et al.
Assay and Drug Development Technologies|February 4, 2009
Characterization and optimization of a red-shifted fluorescence polarization ADP detection assayKaren M Kleman-Leyer, Tony A Klink, Andrew L Kopp, et al.
Pageof 12